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Introduction: Pharmaceutical companies have invested considerable financial resources in 
developing analgesics. Often, the compounds used in these medicines are naturally occurring, 
such as aspirin and opioids. Mambalgin-1, an analgesic peptide component of the African Black 
Mamba venom, has been shown to have comparable analgesic effects to morphine but does not 
induce the debilitating withdrawal affects. Extracting this peptide is expensive and dangerous 
work; our objective was the development of a recombinant system producing this peptide 
without milking snakes.  
Purpose: Using recombinant DNA technology, we sought to produce high quantities of pure, 
functional Mambalgin-1 in a safe and cost effective manner through a cassette system in the 
yeast Pichia pastoris. Since this project is part of the International Genetically Engineered 
Machine (iGEM) competition and iGEM is dedicated to the sharing of DNA through a process of 
standardization, we also sought to standardize the pGAPzα expression vectors for future iGEM 
use. 
Method: The original multiple cloning sites (MCS) of the pGAPzα vectors were removed 
through restriction digestion and standardized MCS were ligated into the vectors. Mambalgin-1 
cDNA was then inserted into one standardized vector. Copies of the resulting plasmid were then 
linearized and transformed into Pichia pastoris. 
Results: Preliminary results show successful growth of Pichia in presence of Zeocin, an 
indicator of successful transformation with pGAPzα plasmid sequences. Standardization of the 
pGAPzαC plasmid has been confirmed by analytical digestion and PCR analysis. Further, 
addition of the Mamblagin-1 cDNA has been confirmed by analytical digest.  
Conclusion: We have modified Pichia pastoris expression vectors for future iGEM use.  
Proteins produced using these plasmids can be tagged for secretion and expressed as a his and 
myc-tagged fusion, allowing for easier purification and detection. Work is ongoing to verify the 
presence of the Mambalgin-1 cDNA in P. pastoris.  Purified Mambalgin-1 can then be tested for 
functional binding to acid sensing ion channels (ASIC) and may ultimately prove useful as a 
potent, non-opiate analgesic. 
